Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Neuromodulation for relieving phantom limb pain

Official title: Neuromodulation Methods for Suppressing Phantom Limb Pain

Run by Skolkovo Institute of Science and Technology · NCT06644807 · Data updated 2026-11-12

This study is testing different ways to use electrical stimulation to help people who have had a limb amputated and are suffering from phantom limb pain feel better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorSkolkovo Institute of Science and Technology
Academic / other
Locations2 sites (Moscow, Moscow and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedSeptember 1, 2028
Study endsMay 1, 2029
Registry record updatedOctober 16, 2024
Trial IDNCT06644807 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 who have experienced an amputation of the upper or lower limb and suffer from chronic pain rated between 4 and 10 on the Visual Analog Scale.

Probably not a fit

Patients with severe psychiatric disorders, significant somatic pathology, or a history of certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of various neuromodulation techniques, including Motor Cortex Stimulation, Spinal Cord Stimulation, Peripheral Nerve Stimulation, and Dorsal Root Ganglion Stimulation, in alleviating phantom limb pain in patients who have undergone limb amputation. Participants will have electrodes implanted to stimulate peripheral nerves and other targeted areas to assess pain relief. The study focuses on individuals experiencing chronic pain at least six months post-amputation, aiming to provide a novel approach to managing this debilitating condition.

Why it matters

Potential benefit: If successful, this study could significantly reduce phantom limb pain, improving the quality of life for amputees.

How similar studies have gone: While neuromodulation techniques have been explored in various contexts, this specific application for phantom limb pain is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Amputation of the upper limb at the level of the forearm or upper arm, or amputation of the lower limb at the level of the lower leg or thigh.
* Age between 18 and 65 years.
* Duration since amputation is at least 6 months.
* Presence of persistent chronic pain syndrome rated between 4 and 10 on the Visual Analog Scale (VAS).
* Absence of pregnancy at the time of implantation, confirmed by a pregnancy test (for female participants only).
* Signed consent to participate in the study.

Exclusion Criteria:

* Presence of severe somatic pathology that hinders surgical treatment and participation in the study.
* Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts.
* Presence of severe orthopedic deformity in the limb above the level of amputation.
* History of cancer.
* History of epilepsy.
* Complicated traumatic brain injury (TBI) or a history of stroke.
* Inability to undergo electrostimulation due to other somatic pathology.
* Purulent-septic pathology.
* Drug addiction (including a history of).
* Congenital anomaly of upper limb development.
* Anomalies in the development of the central and peripheral nervous systems.

Where it's running

  • Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia
    Moscow, Moscow, Russia
    Recruiting
  • Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia
    Moscow, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.